Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection.

Müller A, Oertli M, Arnold IC.

Cell Commun Signal. 2011 Nov 1;9(1):25. doi: 10.1186/1478-811X-9-25.

2.

The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders.

Arnold IC, Hitzler I, Müller A.

Front Cell Infect Microbiol. 2012 Feb 16;2:10. doi: 10.3389/fcimb.2012.00010. eCollection 2012. Review.

3.

Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.

Salama NR, Hartung ML, Müller A.

Nat Rev Microbiol. 2013 Jun;11(6):385-99. doi: 10.1038/nrmicro3016. Epub 2013 May 8. Review.

4.

DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M, Müller A.

J Clin Invest. 2012 Mar;122(3):1082-96. doi: 10.1172/JCI61029. Epub 2012 Feb 6.

5.

The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori.

Cooke CL, Huff JL, Solnick JV.

FEMS Immunol Med Microbiol. 2005 Jul 1;45(1):11-23. Review.

6.

Update on the immunologic basis of Helicobacter pylori gastritis.

Tummala S, Keates S, Kelly CP.

Curr Opin Gastroenterol. 2004 Nov;20(6):592-7.

PMID:
15703688
7.

Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies.

Sundquist M, Quiding-Järbrink M.

Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):733-44. doi: 10.1586/egh.10.71. Review.

PMID:
21108593
8.

Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes.

Portal-Celhay C, Perez-Perez GI.

Clin Sci (Lond). 2006 Mar;110(3):305-14. Review. Retraction in: Clin Sci (Lond). 2015 Feb;128(4):281.

PMID:
16464172
9.

Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia.

Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Müller A.

Gastroenterology. 2011 Jan;140(1):199-209. doi: 10.1053/j.gastro.2010.06.047. Epub 2010 Jun 22.

10.

Host response and vaccine development to Helicobacter pylori infection.

Blanchard TG, Czinn SJ, Nedrud JG.

Curr Top Microbiol Immunol. 1999;241:181-213. Review.

PMID:
10087662
11.

Interplay between Helicobacter pylori and the immune system. Clinical implications.

Szczepanik M.

J Physiol Pharmacol. 2006 Sep;57 Suppl 3:15-27. Review.

12.

Inflammation, immunity, and vaccines for Helicobacter pylori infection.

Velin D, Straubinger K, Gerhard M.

Helicobacter. 2016 Sep;21 Suppl 1:26-9. doi: 10.1111/hel.12336. Review.

PMID:
27531535
13.

[Helicobacter pylori infection and phagocytosis].

Demiray E, Bekmen N.

Mikrobiyol Bul. 2008 Jan;42(1):177-84. Review. Turkish.

PMID:
18444577
14.

Morphological and Cellular Features of Innate Immune Reaction in Helicobacter pylori Gastritis: A Brief Review.

Ieni A, Barresi V, Rigoli L, Fedele F, Tuccari G, Caruso RA.

Int J Mol Sci. 2016 Jan 15;17(1). pii: E109. doi: 10.3390/ijms17010109. Review.

15.

Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori.

Mori J, Vranac T, Smrekar B, Cernilec M, Serbec VČ, Horvat S, Ihan A, Benčina M, Jerala R.

Vaccine. 2012 Aug 31;30(40):5856-63. doi: 10.1016/j.vaccine.2012.07.011. Epub 2012 Jul 20.

PMID:
22819990
16.

Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation.

Lee KS, Kalantzis A, Jackson CB, O'Connor L, Murata-Kamiya N, Hatakeyama M, Judd LM, Giraud AS, Menheniott TR.

PLoS One. 2012;7(2):e30786. doi: 10.1371/journal.pone.0030786. Epub 2012 Feb 1.

17.

Helicobacter pylori-induced gastric inflammation and gastric cancer.

Wang F, Meng W, Wang B, Qiao L.

Cancer Lett. 2014 Apr 10;345(2):196-202. doi: 10.1016/j.canlet.2013.08.016. Epub 2013 Aug 24. Review.

PMID:
23981572
18.

Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection.

Barry DP, Asim M, Scull BP, Piazuelo MB, de Sablet T, Lewis ND, Coburn LA, Singh K, Ellies LG, Gobert AP, Chaturvedi R, Wilson KT.

PLoS One. 2011;6(12):e29046. doi: 10.1371/journal.pone.0029046. Epub 2011 Dec 14.

19.

Inflammation, immunity and vaccines for Helicobacter pylori.

Del Giudice G, Michetti P.

Helicobacter. 2004;9 Suppl 1:23-8. Review.

PMID:
15347302
20.

Review article: exploring the link between Helicobacter pylori and gastric cancer.

Kuipers EJ.

Aliment Pharmacol Ther. 1999 Mar;13 Suppl 1:3-11. Review.

Supplemental Content

Support Center